DECISION OF THE EEA JOINT COMMITTEE No 238/2021

of 24 September 2021

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/495]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Delegated Regulation (EU) 2020/1737 of 14 July 2020 amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of certain drug precursors in the list of scheduled substances ( 1 ) is to be incorporated into the EEA Agreement.

(2) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 15x (Regulation (EC) No 273/2004 of the European Parliament and of the Council) of Chapter XIII of Annex II to the EEA Agreement:

‘—

32020 R 1737 : Commission Delegated Regulation (EU) 2020/1737 of 14 July 2020 ( OJ L 392, 23.11.2020, p. 1 ).’

Article 2

The text of Delegated Regulation (EU) 2020/1737 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 25 September 2021, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 24 September 2021.

For the EEA Joint Committee

The President

Rolf Einar FIFE

( 1 ) OJ L 392, 23.11.2020, p. 1 .

( *1 ) No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2024/495/oj

ISSN 1977-0677 (electronic edition)